Personalized medicine in schizophrenia: predicting relapse, treatment response and the potential benefit of add-on anti-inflammatory agents – PerMedSchiz
Monsieur Nicolas GLAICHENHAUS (Université Côte d'Azur)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Medical University of Vienna
Université Côte d'Azur
Copenhagen University Hospital
Help of the ANR 411,323 euros
Beginning and duration of the scientific project: June 2020 - 36 Months